Abstract:This study presents an innovative approach to combat antibiotic‐resistant Gram‐negative bacteria by utilizing self‐assembling nanoparticles that deliver nitric oxide (NO). These nanoparticles, combined with polymyxin B, significantly enhance antibacterial efficacy at lower NO concentrations, disrupting bacterial membranes and reducing resistance development. The findings offer a promising pathway for next‐generation antimicrobial therapies. In the current battle against antibiotic resistance, the resilience of Gram‐negative bacteria against traditional antibiotics is due not only to their protective outer membranes but also to mechanisms like efflux pumps and enzymatic degradation of drugs, underscores the urgent need for innovative antimicrobial tactics. Herein, this study presents an innovative method involving the synthesis of three furoxan derivatives engineered to self‐assemble into nitric oxide (NO) donor nanoparticles (FuNPs). These FuNPs, notably supplied together with polymyxin B (PMB), achieve markedly enhanced bactericidal efficacy against a wide spectrum of bacterial phenotypes at considerably lower NO concentrations (0.1–2.8 μg mL−1), which is at least ten times lower than the reported data for NO donors (≥200 μg mL−1). The bactericidal mechanism is elucidated using confocal, scanning, and transmission electron microscopy techniques. Neutron reflectometry confirms that FuNPs initiate membrane disruption by specifically engaging with the polysaccharides on bacterial surfaces, causing structural perturbations. Subsequently, PMB binds to lipid A on the outer membrane, enhancing permeability and resulting in a synergistic bactericidal action with FuNPs. This pioneering strategy underscores the utility of self‐assembly in NO delivery as a groundbreaking paradigm to circumvent traditional antibiotic resistance barriers, marking a significant leap forward in the development of next‐generation antimicrobial agents.

Furoxan-Bearing Micelles for Nitric Oxide Delivery

Nitric Oxide-Releasing Polymeric Furoxan Conjugates

Synthesis of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of 1-Oxo-oridonin with Anti-Proliferative Activity

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin As Potential Anti-Tumor Agents.

Synthesis and Evaluation of Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid As Anti-Tumor Agents.

Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents

Photo-degradable micelles for co-delivery of nitric oxide and doxorubicin

Nitric oxide delivery by core/shell superparamagnetic nanoparticle vehicles with enhanced biocompatibility.

Synthesis and Nitric Oxide Releasing Properties of Novel Fluoros-Nitrosothiols

Synthesis and bioactivities of furoxan-based nitric oxide-releasing ferulic acid derivatives

Enhanced Nitric Oxide Delivery Through Self‐Assembling Nanoparticles for Eradicating Gram‐Negative Bacteria

Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy

Functional Biodegradable Nitric Oxide Donor-Containing Polycarbonate-Based Micelles for Reduction-Triggered Drug Release and Overcoming Multidrug Resistance.

Enhanced Oral NO Delivery through Bioinorganic Engineering of Acid-Sensitive Prodrug into a Transformer-like DNIC@MOF Microrod

Gelatin-siloxane nanoparticles to deliver nitric oxide for vascular cell regulation: synthesis, cytocompatibility, and cellular responses.

Synthesis and Anti-Lung Cancer Activity of Nitric Oxide-Donating Derivatives of Farnesylthiosalicylic Acid

Stepwise Nitric Oxide Release and Antibacterial Activity of a Nitric Oxide Photodonor Hosted within Cyclodextrin Branched Polymer Nanocarriers

Synthesis and Modeling Studies of Furoxan Coupled Spiro-Isoquinolino Piperidine Derivatives as NO Releasing PDE 5 Inhibitors

Advances in Inorganic-Based Colloidal Nanovehicles Functionalized for Nitric Oxide Delivery.

Nitric Oxide-Releasing Cyclodextrins.